Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced a partnership with the non-profit organization This Is My Brave to support Teen Mental Health Month in August. This collaboration aims …
Neuronetics Partners with This Is My Brave for Teen Mental Health Month Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that Aetna has updated its coverage policy for transcranial magnetic stimulation (TMS) to include adolescents aged 15 and older with major depressive …
Aetna Expands TMS Coverage to Adolescents with Major Depressive Disorder Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that California Medicaid, known as Medi-Cal, will now cover transcranial magnetic stimulation (TMS) for both adults and adolescents aged 15 and older …
Neuronetics Secures Medi-Cal Coverage for TMS Treatment in California Read MoreMALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced significant updates from major insurers that will broaden access to transcranial magnetic stimulation (TMS) for younger patients. BlueCross BlueShield (BCBS) of …
Expanded Insurance Coverage Boosts Access to TMS Treatment for Adolescents Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced that Humana, a major U.S. health insurer, has updated its coverage policy to include adolescents aged 15-21 in response to …
Humana Pioneers Coverage Expansion for Adolescent Depression Treatment Following FDA Clearance Read More MALVERN, PA — In a recent disclosure, Pennsylvania-based biotech firm Neuronetics (NASDAQ: STIM) announced its first-quarter financial performance for 2024, revealing a promising 12% increase in revenue compared to the …
Neuronetics Boasts 12% Revenue Increase, Expands Depression Treatment Sector Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a medical technology firm, awarded Restricted Stock Units (RSUs) equivalent to 55,650 shares of common stock to thirteen newly hired non-executive employees on …
Neuronetics Awards Stock Options to New Employees as Inducement Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced that the U.S. Food and Drug Administration (FDA) has cleared NeuroStar TMS (transcranial magnetic stimulation) for use as a first-line add-on …
FDA Clears NeuroStar TMS Therapy for Adolescents with Depression, A First in the Field Read More